UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Beyond aspirin and metformin: The untapped potential of drug repurposing in oncology

European journal of cancer (1990), 2017-02, Vol.72, p.S121-S122

2017

Link zum Volltext

Verfügbarkeit prüfen

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

Annals of the rheumatic diseases, 2004-09, Vol.63 (9), p.1155-1158

2004

Link zum Volltext

Verfügbarkeit prüfen

Finding existing drugs potentially active against BRCA-mutated breast cancers: A literature-based approach

European journal of cancer (1990), 2020-10, Vol.138, p.S55-S55

2020

Link zum Volltext

Verfügbarkeit prüfen

Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing

Annals of the rheumatic diseases, 2001-12, Vol.60 (12), p.1131-1136

2001

Link zum Volltext

Verfügbarkeit prüfen

1089 - Beyond aspirin and metformin: The untapped potential of drug repurposing in oncology

European journal of cancer (1990), 2017-02, Vol.72, p.S121-S122

2017

Link zum Volltext

Verfügbarkeit prüfen

Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope

Annals of the rheumatic diseases, 2007-03, Vol.66 (3), p.364-369

2007

Link zum Volltext

Verfügbarkeit prüfen

Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.330-332

2005

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype

Annals of the rheumatic diseases, 2002-12, Vol.61 (12), p.1090-1094

2002

Link zum Volltext

Verfügbarkeit prüfen

Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent

Ecancermedicalscience, 2016-01, Vol.10, p.610-610

2016

Link zum Volltext

Verfügbarkeit prüfen

Repurposing non-cancer drugs in oncology: Aspirin and metformin are only the tip of the iceberg

Annals of oncology, 2017-11, Vol.28, p.x40-x40

2017

Link zum Volltext

Verfügbarkeit prüfen

Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease

Annals of the rheumatic diseases, 2002-10, Vol.61 (10), p.929-933

2002

Link zum Volltext

Verfügbarkeit prüfen

The Repurposing Drugs in Oncology (ReDO) Project

Ecancermedicalscience, 2014-01, Vol.8, p.442-442

2014

Link zum Volltext

Verfügbarkeit prüfen

PCN224 - TOWARDS CLINICAL ADOPTION OF REPURPOSED DRUGS IN ONCOLOGY: OVERCOMING REGULATORY AND MARKET ACCESS BARRIERS IN EUROPE

Value in health, 2018-10, Vol.21, p.S52-S52

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages

The Journal of immunology (1950), 1993-08, Vol.151 (3), p.1535

1993

Link zum Volltext

Verfügbarkeit prüfen

Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN protein

RNA (Cambridge), 2001-11, Vol.7 (11), p.1531-1542, Article S135583820101442X

2001

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens

Journal of rheumatology, 2001-02, Vol.28 (2), p.284

2001

Link zum Volltext

Verfügbarkeit prüfen

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

Annals of the rheumatic diseases, 2004-12, Vol.63 (12), p.1587-1593

2004

Link zum Volltext

Verfügbarkeit prüfen

The C-terminal RG Dipeptide Repeats of the Spliceosomal Sm Proteins D1 and D3 Contain Symmetrical Dimethylarginines, Which Form a Major B-cell Epitope for Anti-Sm Autoantibodies

The Journal of biological chemistry, 2000-06, Vol.275 (22), p.17122-17129

2000

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the osteogenic stromal cell line MN7: Identification of secreted MN7 proteins using two‐dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing

Journal of bone and mineral research, 1994-06, Vol.9 (6), p.903-913

1994

Link zum Volltext

Verfügbarkeit prüfen

Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus

Journal of rheumatology, 2004-12, Vol.31 (12), p.2480

2004

Link zum Volltext

Verfügbarkeit prüfen

Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders

Clinical and experimental rheumatology, 1999-03, Vol.17 (2), p.205

1999

Link zum Volltext

Verfügbarkeit prüfen

Changes in the liver protein pattern of female wistar rats treated with the hypoglycemic agent SDZ PGU 693

Life sciences (1973), 1998, Vol.63 (25), p.2243-2250

1998

Link zum Volltext

Verfügbarkeit prüfen

Cholangiocyte-specific rat liver proteins identified by establishment of a two-dimensional gel protein database

Electrophoresis, 1998-12, Vol.19 (18), p.3207-3212

1998

Link zum Volltext

Verfügbarkeit prüfen

Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization - mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry

Electrophoresis, 2000-06, Vol.21 (11), p.2266-2283

2000

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of recombinant RO/SSA, La/SSB, Sm and U1 RNP autoantigens in clinical diagnosis

Journal of clinical laboratory analysis, 1996, Vol.10 (1), p.57-58

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(51)
Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Female
(30)
Biological And Medical Sciences
(27)
Medical Sciences
(21)
Male
(19)
Adult
(18)
Infectious Diseases
(12)
Rheumatology
(12)
Adolescent
(11)
Amino Acid Sequence
(11)
Animals
(10)
Middle Aged
(10)
Molecular Sequence Data
(10)
Child
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Diseases Of The Osteoarticular System
(7)
Immunology
(7)
Laboratories
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Beyond aspirin and metformin: The untapped potential of drug repurposing in oncology

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

Finding existing drugs potentially active against BRCA-mutated breast cancers: A literature-based approach

Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing

1089 - Beyond aspirin and metformin: The untapped potential of drug repurposing in oncology

Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope

Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus

Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype

Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent

Repurposing non-cancer drugs in oncology: Aspirin and metformin are only the tip of the iceberg

Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease

The Repurposing Drugs in Oncology (ReDO) Project

PCN224 - TOWARDS CLINICAL ADOPTION OF REPURPOSED DRUGS IN ONCOLOGY: OVERCOMING REGULATORY AND MARKET ACCESS BARRIERS IN EUROPE

Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages

Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN protein

Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

The C-terminal RG Dipeptide Repeats of the Spliceosomal Sm Proteins D1 and D3 Contain Symmetrical Dimethylarginines, Which Form a Major B-cell Epitope for Anti-Sm Autoantibodies

Characterization of the osteogenic stromal cell line MN7: Identification of secreted MN7 proteins using two‐dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing

Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus

Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders

Changes in the liver protein pattern of female wistar rats treated with the hypoglycemic agent SDZ PGU 693

Cholangiocyte-specific rat liver proteins identified by establishment of a two-dimensional gel protein database

Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization - mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry

Evaluation of recombinant RO/SSA, La/SSB, Sm and U1 RNP autoantigens in clinical diagnosis

Suchergebnisse filtern